MedPath

Phase Out as a treatment for Tinnitus

Completed
Conditions
tinnitus, Phase Out, oorsuizen
Registration Number
NL-OMON23737
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. Subjects > 18 years;
2. Unilateral or bilateral tinnitus;
3. Predominant tone tinnitus by history;
4. Tinnitus for minimum of 3 months;

Exclusion Criteria

1. Acoustic neurinoma;
2. Aortic/ outflow tract stenosis;
3. Pulsatile tinnitus;
4. Pregnancy;
5. Inability to correct use of test equipment: unable to cooperate during audiologic examination;
6. Known tinnitus etiology, which would demand other treatment;
7. Hearing loss greater than 60 decibel compared with standardized normal hearing on standard frequencies of a tone audiogram (250; 500; 1000; 2000; 4000 en 8000 hertz).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The major aim of this study is disappearance (report mark) of the tinnitus lasting many hours (time).
Secondary Outcome Measures
NameTimeMethod
Besides the mojor aims, different questionnaires will be used to determine for which kind of tinnitus patients, this treatment is most effective (THI, TRQ, VE, HADS, SF-36, Eysenck, type D personality, SSQ and TCSQ).
© Copyright 2025. All Rights Reserved by MedPath